å»è¬åå ¬è¡šãããæŽå¯
è¬ç©ã¿ã€ãïŒã¢ãããªãã¯ã¹ããã€ãïŒãã¹ãã¹ããã³ããã³ãããã³ãªã©ïŒãåºæ¿å€ïŒäŸãã°ãã¢ã³ãã§ã¿ãã³ãã«ãã§ã€ã³ããšãã§ããªã³ïŒããšãªã¹ãããšãã³ïŒEPOïŒããã³è¡æ¶²ããŒã¹ã¿ãŒã人éã®æé·ãã«ã¢ã³ïŒHGHïŒããã³ãããããããã³ãããããããã³ããããããã³ããããããã³ã¬ãžã³å容äœã®ã¡ãžã¥ã¬ãŒã¿ãŒïŒdirtaïŒãdirmedsãªã©ã®ããã©ãŒãã³ã¹åäžè¬ç©åžå Žåžå Žãããã©ãŒãã³ã¹ãåäžãããåžå Žåžå Žãåäžããã åå¿èŠèŽïŒèªç¥ãšã³ãã³ãµãŒïŒãããã³ãã®ä»ïŒã€ã³ã¹ãªã³æ§æé·å åãªã©ïŒïŒãã¢ããªã±ãŒã·ã§ã³ïŒã¢ã¹ã¬ããã¯ããã©ãŒãã³ã¹ãèªç¥æ©èœåŒ·åïŒåŠçãå°éå®¶ïŒãããã£ãŒãã«ãšçèã®åŒ·åãè»äºã... ãã£ãšèŠã
æäœã¯ã现èãçµç¹ã®ç¹å®ã®ããŒã«ãŒã«çµåããå ç«ã·ã¹ãã ã«ãã£ãŠäœãããã¿ã³ãã¯è³ªã§ãã ã¢ãã¯ããŒãã« æäœã¯ãç æ°ã®èšºæãæ²»çã«äœ¿çšã§ããå®éšå®€ã§äœãããæäœã®äžçš®ã§ãã ããæ²»çã§ã¯ã ã¢ãã¯ããŒãã« æäœ ç现èãçŽæ¥æ®ºããè «çã®è¡ç®¡ã®çºçã劚ããããå ç«ã·ã¹ãã ãç现èãæ®ºãã®ãå©ããããšãã§ããããããå€çºæ§ç¡¬åçãªã©ã®æ ¢æ§çŸæ£ããæŠç¥çã³ã©ãã¬ãŒã·ã§ã³ã«é¢ããåžå Žéžæã®åŒ·åãªçŠç¹ã¯ãäžæ±ã»ã¢ãžã¢å€ªå¹³æŽæäœå»è¬ååžå Žæé·ãçœåŒããäž»èŠãªèŠå ã§ãã ããšãã°ã2021幎11æã«ã¯ã驿°çãªå ç«è «çåŠçæ³ããã³ç²Ÿå¯å»åŠã®ç ç©¶ãéçºãããã³åååã«çŠç¹ãåãããäž»èŠãªãã€ãªå»è¬åäŒç€Ÿã§ã... ãã£ãšèŠã
Docosahexaenoicã®é ž(DHA)ã¯æãå¿ èŠãªãªã¡ã¬3èèªé žã®1ã€ã§ãã æ¹åãããå¿ã®å¥åº·ãããããèŠéããã³æžããããççæå¶ã®å¿çã®ãããªå©ç¹ã«ãªã³ã¯ãããŸãã DHAã¯ã身äœã®ãããã现èã§çºèŠãããåŠåš äžãäžåŠçã®éã«è³ã®çºéã«éèŠãªåœ¹å²ãæãããŠããŸãã DHAã¯ãç®èãç®ãè³ã®å¥åº·ã«äžå¯æ¬ ã§ãã äœãå¿ èŠãªååãªDHAãçæã§ããªããããé£äºãéããŠåŸãããå¿ èŠããããŸããã°ããŒãã«DHAãµããªã¡ã³ãåžå Žãè©äŸ¡ããããšæšå®ããã US$ 1,385.8çŸäž ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠7.0%ã® äºå ±æéäž (2021-2028).å³1.ã°ããŒ... ãã£ãšèŠã
IVFã¯ã女æ§ã®çæ®ã·ã¹ãã ã人工çã«åµçްèãäœæããããšã奚å±ãããã®åŸåç©«ãããã©ãã§å粟ãããåå®®ã«å ¥ããããè£å©åçæè¡ã®äžçš®ã§ãã å䜵çã«ãããIVFã¹ãã·ã£ãªã¹ãã¯ãIVFæ²»çãåããæ£è ã«å»è¬åãé£åã®ãµããªã¡ã³ããæäŸããŠããŸãã IVFã®åŠçœ®ã®ããã·ãŒãžã£ã¯åµå·£ã®åºæ¿ãæåµã®èªå°ãoocyteã®åç©«ã粟åã®å粟ããã³æ³šå ¥ã®ããã®å粟ãããoocytesã®èŒžéãå«ãã§ããŸãã æåµããã³ãŸã泚å°å¯èœãªæ³šå°åšãæåããã®ã«äœ¿çšãããClomipheneã®ãããªIVFã®åŠçœ®ã®ããã«äžè¬çã§ããããŸããŸãªè¬å€ã¯åŠåš ãç¶æããããã«ããã²ã¹ããã³ãäœãåºããã«ã¢ã³(GnRH)ããã³å°... ãã£ãšèŠã
æ±ããå¿èç åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎äžççãªDilated Cardiomyopathy åžå ŽèŠæš¡ã¯æšå®ããã 2026幎ã®USD 4.3åã§è©äŸ¡ãããUSD 7.9ã«éããèŠèŸŒã¿ 2033幎(æå20幎)ã«å¢æ®ç(CAGR)ã8.5%å¢èš 2026幎ïœ2033幎ãããã£ãŒã«Dilated Cardiomyopathyåžå Žã¯æ²»çè¬ã®ç¯å²ãæž¡ããŸã å¿èã®çèæ©èœäžå šã管çããããšãç®æãã蚺æãããã¯ã å¿è匷ãçµæãæ¹åããŠäžããã äž»ãªè£œåã«ããŽãªã«ã¯ã ããŒã¿ãããã«ãŒãACEã®æå¶å€ã®ãããªè¬å€ã®åŠçœ®ã angiotensinã®å容åšã®ãããã«ãŒãããã³ å©å°¿è¬,... ãã£ãšèŠã
å®å®å»çãµãŒãã¹åžå ŽããµãŒãã¹ã¿ã€ãå¥ïŒé£è¡åå»çãµãŒãã¹ãæ©å å»çãµããŒããµãŒãã¹ãé£è¡åŸãªãããªããŒã·ã§ã³ããã³å埩ãµãŒãã¹ïŒãæ€æ»ã¿ã€ãå¥ïŒèŽèŠåŠãå¿èºåŠãæ¶ååšç§ãç®èç§ãçéªšæ ŒåŠãè¡åå¥åº·åŠããªãããã¯ãã£ããã«ã¹ãèšåºæ€æ»ããã³çŒç§æ€çŒïŒããµãŒãã¹ãããã€ããŒå¥ïŒæ°éããã³å ¬å ±ïŒããšã³ããŠãŒã¶ãŒå¥ïŒå®å®é£è¡å£«ãèªç©ºæ©ïŒ éèªéšéïŒAODïŒã®éèªä¹åå¡ããã®ä»ïŒãå°çå¥ïŒåç±³ãã©ãã³ã¢ã¡ãªã«ããšãŒããããã¢ãžã¢å€ªå¹³æŽãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
æäœã¯ããŠã€ã«ã¹ã现èãªã©ã®ç¹å®ã®ç°ç©ã«ç¹å®ã®ãã€ã³ãã«ããèªèº«ãæ·»ä»ã§ããããã«ããŸãã¯ç¹å®ã®åœ¢ç¶ãšãµã€ãºã§ããå ç«çްèã«ãã£ãŠäœãããã¿ã³ãã¯è³ªã§ãã æ·»ä»ããããšã«ãããæäœã¯ããããã®äŸµå ¥è ãææãããããšãé²ãããšãã§ããŸãã æäœã«ã¯ãã«ã¯2ã€ã®ã«ã¯ãã«ã§ããæ²»çã§ãã æäœåºæ¬çã«ã¯ãäœãããããç æ°ã«å¯ŸããŠèªåèªèº«ãå®ãããã«çæããã¿ã³ãã¯è³ªã§ãã äŸãã°ãæäœCasirivimabãšImdevmabã®ã¢ãã¯ããŒãã«æäœã«ã¯ãã«ã¯ãCOVID-19ææããããéãå埩ããããã®è¯å®çãªçµæã瀺ãããšãå®èšŒãããŠããŸããäžçã®æäœã«ã¯ãã« åžå Žãè©äŸ¡ãããŸãã US$ 2,11... ãã£ãšèŠã
泚å°å¯èœãª å»è¬åããªããªãŒã·ã¹ãã çµå£è¬é éã·ã¹ãã 代æ¿ãšããŠäœ¿çšããããšãã§ããŸãã æ³šå°ã¯ãçµå£è¬æäžã®åœ¢æ ãšèããããè¬ã¯ããæ¥éã«åžåãããããšãå¯èœã«ããŸããã¢ããªã«ã®æ³šå°å¯èœãªè¬å€ã®åžå Žã¯è©äŸ¡ããããšæšå®ãããŸã US$ 284.5 ã¡ãŒãã« ãåãåãã 2022幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠4.7%(çšæ) äºå ±æéäž (2022-2030).ãããã£ãŒã« 1. ã¢ããªã«ã®æ³šå°å¯èœãªè¬å€ã®åžå Žã¯äŸ¡å€ãååã®ã¿ã€ãã2022ã«ããå€ã®åèªã®(%)ãå ±æããŸã埪ç°åšçŸæ£ãç³å°¿ç ããããªã©ã®æ ¢æ§çŸæ£ã®å¢å€§ãäºæž¬æéäžã«åžå Žæé·ãä¿ãããšãæåŸ ãããŸããé£çæŽ»ç¿æ £ã®å€åã¯ãèèªãš... ãã£ãšèŠã
ãŠã£ã«ãœã³ç ã¯ãããŸããŸãªäœã«èç©ãããéå°ãªé ã«ãã£ãŠç¹åŸŽä»ãããããŸããªéºäŒçç¡ç§©åºã§ã ãã£ãã·ã¥, ç¹ã«èèã§, è³, ç®ã®ç²ã. ç æ°ã¯é²è¡æ§ã§ãããå·Šãæ²»çãããŠããªãå Žåã¯ãèè(èè)çŸæ£ãäžæ¢ç¥çµç³»æ©èœé害ãããã³æ»ãåŒãèµ·ããå¯èœæ§ããããŸãã ãŠã£ã«ãœã³ç ã®ç æ°ã®åŸŽåãçç¶ã¯éåžžã6æ³ãã45æ³ã®éã«æåã«çŸããŸãããããã圌ãã¯å代ã®å¹Žã®éã«æãé »ç¹ã«å§ãŸããŸãã ãŠã£ã«ãœã³ç ã¯ãè硬å€ãšã¬ã³ã¿ã¯å€æ§ãšããŠç¥ãããŠããŸãã æ©æèšºæãšæ²»çã¯ãæ·±å»ãªé·æé害ãšçåœãè ããå䜵çãé²ããŸãã ãŠã£ã«ãœã³ç ã¯ãåžå°çŸæ£ã®åœå®¶æ©é¢ãInc.(NORD)ã«ãããšããŠã£ã«ãœã³ç ã¯ã... ãã£ãšèŠã
鎚ã¯ç æ°ã«æ¯èŒçèæ§ããããŸãããä»ã®çš®é¡ã®å®¶çŠœã«ææããŠããç æ°ãéã¶ããšãç¥ãããŠããŸãã ããããã¢ãã«ã®äžè¬çãªç æ°ã®ããã€ãã«ã¯ãã¢ãã«ãŠã€ã«ã¹èçãã¢ãã«ãã©ããããã¥ã¬ã·ã¹ãããã³ã¢ãã©æ¯æ§çãå«ãŸããŸãã ãããã®ç æ°ã®å€ãã®ããã®åŠçœ®ããªãã®ã§ãã¢ãã«ãã©ããã¢ãã«èçãªã©ãã¢ãã«ãäºé²ããããšãéèŠã§ãã ãŸããé©åãªããŠãžã³ã°ã管çãææ°ãããã³éŽšãžã®æ é€ãæäŸãããšãããããç æ°ã«ææã«ããããšãã§ããŸããäžççãªã¢ãã«è¬ãšã¯ã¯ãã³åžå Žã¯ã 1,777.0çŸäžå ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠7.7%(çšæ) äºå ±æéäž (2021-2028).... ãã£ãšèŠã
ç¹å®ã®æ£è ã®å¿ èŠæ§ã«åŸã£ãŠåŠçœ®ãäœæããããã«ç©è³ªãçµåããæ··åãããããŸãã¯å€æŽããããã»ã¹ã¯è¬ç©ã®æ··åãšããŠç¥ãããŠããŸãã æ··åã¯2ã€ä»¥äžã®è¬ãæ··åããããã»ã¹ã§ãã åã ã®ååŠè¬åã¯æ£è ã®ããã«èŠæ±ãããå³å¯ãªåŒ·ãããã³é©é圢æ ã§æ··åãããŸãã é åè¬ã¯ã鿥å»ã®èŠæ±ã«åºã¥ããŠèª¿è£œãããŸãã ç±³åœé£åå»è¬åå±(FDA)ã¯ãäžè¬çã«FDAã®èšåºè©ŠéšãåããŠããè¬ããæãæåãèŠå¶ããæ¿èªãåããã æ£è ãç±³åœé£åå»è¬åå±(FDA)ã®æ¿èªè¬ã§æ²»çã§ããªãå Žåã¯ãé åãè¡ãããŸããç±³åœã®ãªãã£ãµãŒååç©è¬å±åžå Žã§ã¯è©äŸ¡ããããšæšå®ããã US$ 219.2 çŸäž ãåãåãã 2021幎 å±... ãã£ãšèŠã
èçŸæ£ã¯ã(éºäŒå)ãç¶æ¿ãããããŸãã¯ãŠã€ã«ã¹(èçAãèçBãèçC)ãªã©ã®èèãæå·ããéå°ãªã¢ã«ã³ãŒã«æåãåŒãèµ·ããèŠå ã«ãã£ãŠåŒãèµ·ããããŸãã è¥æºãèèã®æå·ã«é¢é£ããŠããŸãã èèã¯ãé£ç©ã®æ¶åãå©ããäœå ã®ç©è³ªã®æ¯æ§ãå¶åŸ¡ããäœã®éèŠãªéšåã§ãã è硬å€ã¯èèã®æå·ã®çµæã§ãããåœãè ããããšãã§ããèé害ã«ã€ãªããããšãã§ããŸããéã¢ã«ã³ãŒã«èèªèçŸæ£ãèçãªã©ã®æ ¢æ§èçŸæ£ã®å¢å€§çã¯ãè¥æºã2åç³å°¿ç (DM)ãªã©ã®çæŽ»ç¿æ £ç ã«ããäžæ±å°åã«ããã倧éå£ã®æ ç¹ã§ãèçŸæ£ã®æ²»çã«äœ¿çšãããè¬ã®éèŠãä¿ãããšãæåŸ ãããåžå Žæé·ãä¿é²ããŸããäžæ±ããã³ãã«ã³ã®æ ¢æ§èçŸæ£(CLD... ãã£ãšèŠã
ãªã«ãã¡ã³ãã©ãã°åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎äžçã®Orphanã®è¬å€ã®åžå Žã®ãµã€ãºã¯USDã§äŸ¡å€ããããšæšå®ãããŸã 2026幎ã§175.4åç±³ãã«ã«éããèŠèŸŒã¿ 2033幎ã2026幎ãã9.3%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€º 2033幎é ãããã£ãŒã«ãªãŒãã¡ã³ãã©ãã°åžå Žã¯ãåžå°ãªæ²»çã®éçºã«çŠç¹ãåœãŠãŠããŸã å°ããªæ£è éå£ã«åœ±é¿ãäžããçŸæ£ã æ¿åºãšæ¿åº èŠå¶æ©é¢ã¯ãçšéã¯ã¬ãžãããåžå Žãªã©ã®ã€ã³ã»ã³ãã£ããæäŸããŸã å»è¬åäŒç€Ÿã奚å±ããããã®ç¬å çãã€è¿ éãªæ¿èª ãããã®çæ³ã«æè³ããã åžå°äŸ¡å€ã®é«ãŸã ç æ°ããã€ãªãã¯ãããžãŒã®é²æ©ããããŠæé·ã®æè ã... ãã£ãšèŠã
Gonadotropinè§£æŸã®ãã«ã¢ã³(GnRH)ã®ã¢ãŽãã¹ãã¯åandrogensããã³estrogensãã倧ããå®å šããã³å¹åã®ãããã£ãŒã«ãæã€ããã«èæ ®ãããå»åŠã®é³é ç©ãéæããããŸããŸãªçæ³ã®éã§ãããŸãã ããã«ãè¬ã¯äž»ã«æ£è ãå¿«é©ã«ããçæŽ»ã®è³ªãæ¹åãããŸãåŠçœ®ã®è²»çšãåæžããäœéè§£æŸã®å ¬åŒã®åœ¢æ ã®ããã£ã§æ³šå ¥ãããŸãã ã»ãšãã©ã®æé, åç«è ºããã¯ããã¹ãã¹ããã³ãã«ã¢ã³ãå¢å ãããããšã§é²è¡. ãŸãããã¹ãã¹ããã³ã®çç£ã¯ãæè¡çã«çŸäžžãåãé€ãããŸãã¯è¬ç©çæ³ãéããŠåæ¢ããããšãã§ããŸãã Triptorelinã¯GnRHã®ã¢ãŽãã¹ãã§ããã¹ãã¹ããã³ãäœãããè§Šæ... ãã£ãšèŠã
ç¥çµçã®çã¿ã¯ãæ«æ¢¢ç¹ç¶(AβãAÎŽãCç¹ç¶)ãäžå€®ãã¥ãŒãã³ãããã³äººå£ã®7-10%ã«åœ±é¿ãåãŒããœãããŒãœã¹çè«ã·ã¹ãã ã®ç å€ãŸãã¯ç æ°ã«ãã£ãŠåŒãèµ·ããããã ç¥çµçã®çã¿ã®è€æ°ã®åå ãç¹å®ããããã®èå»¶ã¯ãäžççãªäººå£ãèåãããç³å°¿ç ã®çºççã®å¢å ãæåŸ ãããŠããŸãã ç¥çµçã®çç¶ãæªãçµæãããã³å°é£ãªæ²»çã®æ±ºå®ã®è€éãã¯ãæ ¢æ§ç¥çµçã®è² æ ã«è²¢ç®ããŸãã æãéèŠãªã®ã¯ãç¥çµçã®çã¿ãæã€äººã ã¯ãå¢å ãããè¬ã®åŠæ¹ããã«ã¹ã±ã¢ãããã€ããŒãžã®é »ç¹ãªèšªåããªãã³ã«çã¿ãææçããã®çœ¹æ£çãªã©ã®ç掻ã®è³ªãäœäžããŠããŸãã é害ã«ãããããããç¥çµé害ã®ç çåŠãçè§£ããããã®é²æ©ã¯ã驿°... ãã£ãšèŠã
é«èçã¯ãé«èçãšãåŒã°ãããã»ãªã¢é«èã«ãã£ãŠåŒãèµ·ããããŸãã ãã®çŸæ£ã¯ãæªæ²»çãã¯ã¯ãã³ãä»ããäºé²å¯èœãªå Žåã髿»äº¡çãæããäžççãªé«èçŸæ£æ²»çåžå Žã¯ãè©äŸ¡ããããšæšå®ããã 3,754.1çŸäžå ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ äºæž¬æéã®12.6%ä»¥äž (2021-2028).ãããã£ãŒã« 1. ã°ããŒãã«ã¡ã³ã¿ã³ã«ã« çŸæ£æ²»çåžå Žã·ã§ã¢(%) å€ãå°åå¥ã2021幎è¬ã®æ¿èªã®å¢å ã¯ãäºæž¬æéã«ããã£ãŠåžå Žæé·ãä¿é²ããããšãæåŸ ãããŸãããšãã°ã2018幎ãå»è¬åäŒç€Ÿã§ããGlaxoSmithKline Plc.ã¯ãç±³åœé£åå»è¬åå±(Baxsero)ãããåäŸ2ã1... ãã£ãšèŠã
ãžã«ã¯ã¯ãã³ åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎ã°ããŒãã«ãžã«ã¯ã¯ãã³ åžå ŽèŠæš¡ã¯ç±³ãã«ã§è©äŸ¡ããããšæšå®ããã 2026幎ã«420åç±³ãã«ã«éãããšã2033幎ãŸã§ã«1åç±³ãã«ã«éããèŠèŸŒã¿ 2026幎ãã14.2%ã®ååç©å¹Žéæé·ç(CAGR)ãåºå± 2033幎ããããã£ãŒã«ãžã«ã¯ã¯ãã³åžå Žã¯ãããã€ãã®ç¹å®ã® ã¯ã¯ãã³ãžã«ãŠã€ã«ã¹ææã®äºé²ãæšçãšããã¿ã€ãã ã©ã€ãattenuated ZIKV-LAVåè£ãªã©ã®ã¯ã¯ãã³ã¯ã匱ãããããŠã€ã«ã¹æ ªã䜿çšã㊠匷ããé·ç¶ããããå é€ãåºæ¿ããŠäžããã æŽ»æ§ã¯ã¯ãã³(ã¯ã¯ãã³ãå«ã) ZPIV(ZikaæµåãããæŽ»æ§åã¯ã¯ãã³)ã¯ã... ãã£ãšèŠã
Ioversolåžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033ã°ããŒãã«ã€ãªãŒããŒãŸã«åžå ŽèŠæš¡ã¯ãUSD 1.12ã§è©äŸ¡ããããšæšå®ããã 2026 åç±³ãã«ã2033 åç±³ãã«ã«éããèŠèŸŒã¿ 2026幎ãã2026幎ã«ãããŠ7.3%ã®ååç©å¹Žéæé·ç(CAGR)ãåºå± 2033幎ããããã£ãŒã«Ioversolã®åžå Žã¯äž»ã«äœ¿çšãããå¯Ÿç §åªäœãããã¯ãããæã£ãŠããŸã ãåãåãã 蚺æ ã€ã¡ãŒãžã³ã°, ç¬ç«ããå¯Ÿç §ã®ä»£çåºããã³å°éçãå«ã èšç®ããããã¢ã°ã©ãã£(CT)ãšã¢ãã°ã©ãã£ã®æé ã®ããã®åŠæ¹ã Intravenous Ioversolã¯é«ãããã管ããã³åšå®ã®ããã«åºãå©çšãããŠããŸã... ãã£ãšèŠã